APA (7th ed.) Citation

M, A., S, C., H, M., J, G., ML, L., P, S., . . . E, Y. (2017). Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast cancer research and treatment, 163(3), 461. https://doi.org/10.1007/s10549-017-4202-z

Chicago Style (17th ed.) Citation

M, Asaduzzaman, et al. "Tumour Suppressor EP300, a Modulator of Paclitaxel Resistance and Stemness, Is Downregulated in Metaplastic Breast Cancer." Breast Cancer Research and Treatment 163, no. 3 (2017): 461. https://doi.org/10.1007/s10549-017-4202-z.

MLA (9th ed.) Citation

M, Asaduzzaman, et al. "Tumour Suppressor EP300, a Modulator of Paclitaxel Resistance and Stemness, Is Downregulated in Metaplastic Breast Cancer." Breast Cancer Research and Treatment, vol. 163, no. 3, 2017, p. 461, https://doi.org/10.1007/s10549-017-4202-z.